Pri­or­i­ty re­view vouch­er up­dates: Who's won PRVs, who's bought them, and how much they're sell­ing for

Track­er up­dat­ed on 1/8/25 to note that Ver­tex used one of its three (pub­licly known) PRVs to speed the ap­proval of its new cys­tic fi­bro­sis …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.